I am a high impact, enterprising, and dynamic leader who drives insights & analytics strategy and planning to guide business strategy and that accelerates the commercial decision-making process. I develop and deliver robust data analytics and insights to facilitate a clear and actionable understanding of opportunities and risks that propel business performance and optimize overall efficiency. I collaborate with cross-functional partners (i.e., marketing, market access, medical, clinical, legal, regulatory) to leverage insights and to provide thought leadership that catalyzes business planning and resource allocation decisions. I provide guidance to prioritize appropriate promotional mix and resource allocation decisions for multiple brands and portfolios, while continuing to advance overall analytics and insights rigor and capability development. I possess a motivational management style with a proven history of building, coaching, and empowering high-performing global teams to develop and implement strategies for accelerated business growth.SELECT LEADERSHIP CONTRIBUTIONS* Led the insights and analytics team in collaboration with the brand team to launch Eliquis, the blockbuster anticoagulant that launched third to market, became the market leader with over 50% market share, and generated annual sales of over $12B. * Collaborated with leadership to create a new customer engagement model that re-organized the home office and an 800-person field force (sales, medical affairs, patient experience, market access) into collaborative ecosystems designed around Health Systems. Customer Satisfaction increased by 10% across brands and Trx volume increased by 3% over the original forecast.* Created an enterprise-wide customized Competitive Intelligence (CI) platform using the latest technology and best practices. 50 people started using the platform initially and then usage rocketed to over 2,000 employees in 6 months. The new CI platform increased CI quality and speed by 50% and saved the company over $500k annually based on realized efficiencies.* Collaborated with cross-functional partners to create an omnichannel pilot for Jynarque, including a decision and orchestration engine. Developed KPIs and diagnostic metrics to measure and evaluate performance. New Jynarque patient starts increased by 12% through the pilot period and inspired a full-scale rollout the following year that resulted in a 10% increase in new Jynarque patient starts through the first half of the year. Jynarque is on track to exceed the budget forecast by 8%.